| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 1,869.86 | 1,516.09 | 1,218.82 | 2,789.34 |
Depreciation | -150.81 | -138.53 | -118.2 | -104.93 |
Tax paid | -294.31 | -180.09 | -204.47 | -412.28 |
Working capital | 463.74 | -1,507.52 | -180.36 | 1,492.86 |
Other operating items | ||||
Operating | 1,888.48 | -310.06 | 715.78 | 3,764.98 |
Capital expenditure | 253.5 | 13.3 | 213.22 | 261.49 |
Free cash flow | 2,141.98 | -296.75 | 929 | 4,026.47 |
Equity raised | 26,329.89 | 22,206.72 | 18,813.7 | 14,661.97 |
Investing | 2,276.02 | 1,501.25 | 1,345.98 | 8.26 |
Financing | 7,277.75 | 6,515.35 | 5,752.42 | 3,532.89 |
Dividends paid | 0 | 0 | 56.43 | 56.43 |
Net in cash | 38,025.64 | 29,926.56 | 26,897.54 | 22,286.04 |
According to a statement from the firm, the Travoprost ophthalmic solution (0.004% ionic buffered solution) is both bioequivalent and therapeutically equivalent to the reference listed medication
The company also reported revenue from operations to ₹3433.7 Crore. The EBITDA margin for the quarter that ended on September 30, 2024 stands at 17.5%.
Glenmark Pharmaceuticals Inc, USA, issued a countrywide (US) Class II recall on September 24 this year.
This positive outcome indicates compliance with FDA standards and enhances Glenmark's credibility in the pharmaceutical sector.
In conclusion, the US Food and Drug Administration (USFDA) has issued Form 483 with no observations.
Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.
Revenue from operations grew by 6.9%, reaching ₹3,244.2 Crore compared to ₹3,036 Crore in the same quarter of the previous fiscal year.
Here are some of the stocks that may see significant price movement today: Asian Paints, LTIMindtree, L&T Finance, Zee Entertainment, etc.
The sale will be conducted through the stock exchange mechanism, adhering to applicable legal requirements.
Here are some of the stocks that may see significant price movement today: SBI, Sula Vineyards, Zydus Lifesciences, Kesoram Industries, etc.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
